Interstitial lung disease (ILD) has been recognized as a frequent manifestation associated
with a substantial morbidity and mortality burden in patients with autoimmune rheumatic …

Interstitial pneumonia with autoimmune features (IPAF) is a research classification proposed
by the European Respiratory Society/American Thoracic Society Task Force on …

Background: This document provides clinical recommendations for the diagnosis of
idiopathic pulmonary fibrosis (IPF). It represents a collaborative effort between the American …

Background Diffuse parenchymal lung disease represents a diverse and challenging group
of pulmonary disorders. A consistent diagnostic approach to diffuse parenchymal lung …

Accurately diagnosing fibrotic interstitial lung disease (ILD) is a challenge even for expert
clinicians. It requires multidisciplinary integration of clinical, radiological, and pathological …

Abstract Objectives Myositis-specific autoantibodies (MSAs) are associated with clinical
phenotypes in polymyositis/dermatomyositis (PM/DM). No study has investigated the clinical …

Rationale: Honeycombing on chest computed tomography (CT) has been described in
diverse forms of interstitial lung disease (ILD); however, its prevalence and association with …

Objective To describe the clinical phenotype and natural history of a cohort of patients with
interstitial pneumonia with autoimmune features (IPAF). Methods A retrospective, single …

Background Standard of care for interstitial lung disease (ILD) with a nonspecific interstitial
pneumonia (NSIP) pattern proposes mycophenolate mofetil (MMF) as one of the first-step …

ABSTRACT Background: Interstitial lung diseases (ILDs) are among the most serious
complications associated with systemic rheumatic diseases, and lead to significant morbidity …